These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems. Maj J, Rogóz Z, Dlaboga D, Dziedzicka-Wasylewska M. J Neural Transm (Vienna); 2000; 107(11):1345-59. PubMed ID: 11145008 [Abstract] [Full Text] [Related]
23. Captopril lacks the antidepressant-like activity in animal models. Baran L, Siwanowicz J, Nowak G, Przegaliński E. Pol J Pharmacol Pharm; 1991; 43(4):265-70. PubMed ID: 1667333 [Abstract] [Full Text] [Related]
24. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats. Dziedzicka-Wasylewska M, Rogóz Z. Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033 [Abstract] [Full Text] [Related]
29. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands. Maj J, Rogóz Z, Skuza G. Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678 [Abstract] [Full Text] [Related]
31. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. Eur J Pharmacol; 1999 Jan 08; 364(2-3):123-32. PubMed ID: 9932714 [Abstract] [Full Text] [Related]
33. The need for new and better antidepressants: reboxetine a new option. Dencker SJ. Acta Psychiatr Scand Suppl; 2000 Jan 08; 402():6-11. PubMed ID: 10901153 [Abstract] [Full Text] [Related]